| Drugname |
Patent Number |
Patent Title |
Patent Assignee |
Estimated Expiration |
| Fotemustine |
➤ Sign Up |
Heat shock protein 70 (hsp-70) receptor ligands |
Duke University (Durham, NC) |
➤ Sign Up |
| Fotemustine |
➤ Sign Up |
Compounds and their methods of use |
Agios Pharmaceuticals, Inc. (Cambridge, MA) |
➤ Sign Up |
| Fotemustine |
➤ Sign Up |
Monomethylvaline compounds having phenylalanine side-chain modification at the C-terminus |
Seattle Genetics, Inc. (Bothell, WA) |
➤ Sign Up |
| Fotemustine |
➤ Sign Up |
Anti-FGFR3 antibodies and methods using same |
Genentech, Inc. (South San Francisco, CA) |
➤ Sign Up |
| Fotemustine |
➤ Sign Up |
Method of diagnosing and treating cancer using B-catenin splice variants |
The United States of America, as represented by the Secretary, Department of Health & Human Services (Washington, DC) |
➤ Sign Up |
| Fotemustine |
➤ Sign Up |
Methods for the treatment of Kaposi's sarcoma or KSHV-induced lymphoma using immunomodulatory compounds, and uses of biomarkers |
Celgene Corporation (Summit, NJ) The United States of America, as Represented by the Secretary, Department of Health and Human Services (Washington, DC) |
➤ Sign Up |
| Fotemustine |
➤ Sign Up |
Use of inhibitors of Bruton'S tyrosine kinase (Btk) |
Pharmacyclics LLC (Sunnyvale, CA) |
➤ Sign Up |
| Drugname |
Patent Number |
Patent Title |
Patent Assignee |
Estimated Expiration |
This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial
